Acetazolamide Tablets/Capsules USP

View Part List Download PDF

Strength Select one 500 mg 125 mg 250 mg

Brand Select one Accord Healthcare Inc Westminster Pharmaceuticals Lifestar Pharma LLC Advagen Heritage Pharmaceuticals

Log in for Pricing

---

UPC:

316729331012

Part #:

1308362

Legacy #:

Form:

Capsules

NDC:

16729-0331-01

Packaging:

Each

UPC:

369367209014

Part #:

1315808

Legacy #:

Form:

Capsules

NDC:

69367-0209-01

Packaging:

Each

UPC:

370756720119

Part #:

1307644

Legacy #:

Form:

Tablets

NDC:

70756-0720-11

Packaging:

Each

UPC:

372888048017

Part #:

1315803

Legacy #:

Form:

Tablets

NDC:

72888-0048-01

Packaging:

Each

UPC:

323155288018

Part #:

1097911

Legacy #:

030-2315502-00, 1060335

Form:

Tablets

NDC:

23155-0288-01

Packaging:

Each

UPC:

370756721116

Part #:

1307643

Legacy #:

Form:

Tablets

NDC:

70756-0721-11

Packaging:

Each

• Systemic carbonic anhydrase inhibitor used to reduce intraocular pressure (IOP) in glaucoma patients
• Decreases aqueous humor production, resulting in effective lowering of elevated eye pressure
• Commonly used for acute or severe IOP elevation, including angle-closure glaucoma and pre-surgical management
• Oral administration provides systemic effect, making it effective when topical therapies alone are insufficient
• Onset typically within 1–2 hours, supporting rapid pressure reduction when needed
• Available in immediate-release tablets and extended-release capsules for flexible dosing options
• Often used as adjunct therapy alongside topical glaucoma medications
• Not intended for long-term first-line therapy due to systemic side effect profile

For sale only in the United States.

Related